A team of researchers made a breakthrough in the search for treatments for multiple sclerosis (MS) and other ...
Objective Metabolic reprogramming plays a critical role in modulating the innate and adaptive immune response, but its role ...
The PoNS device led to sustained benefits in gait function in people with multiple sclerosis in a real-world study.
Ozanimodâ–¼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...
Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and ...
The number of people living with neurological disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis and ...
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced promising results from its PoNS Therapeutic Experience Program (PoNSTEP), demonstrating the effectiveness of its PoNS ...
MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...
Tech company Century Health will organize and clean Nira Medical's datasets from more than 3,000 people with MS to aid research.
Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
Pregnancy increases the risk of mental illness among women with multiple sclerosis (MS).Pregnant MS patients have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback